Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Barbakoff

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
The Clinical Teacher|February 25, 2026
The Trainee Perspective on Stressors During the Subinternship ProcessAndrew B Yang, Vidushi Tripathi, Daniel Barbakoff, et al.
Journal of Applied Gerontology : the Official Journal of the Southern Gerontological Society|February 25, 2026
Supportive Environmental Features at Home as Proactive/Reactive Associates of Disability and Mortality Status in Older AdultsDaniel Barbakoff, Kristen Glennie, Mengzhao Yan, et al.
Prostate Cancer and Prostatic Diseases|April 26, 2026
Predictors of fluoroquinolone-resistant bacterial colonization prior to prostate biopsy: a secondary analysis of two randomized trialsDaniel Barbakoff, Gal Wald, Mary Oakley Strasser, et al.
BJUI Compass|January 15, 2026
Long-term outcomes after cytoreductive partial nephrectomy for metastatic renal cell carcinomaAndrea Lopez Sanmiguel, Yash S Khandwala, Emily A Vertosick, et al.
Urologic Oncology|September 6, 2025
Radiomic biomarkers associated with immune checkpoint blockade response for advanced renal cell carcinomaStephen W Reese, Daniel Barbakoff, Burcin Agridag Ucpinar, et al.
Cancers|December 11, 2025
Clinical and Molecular Characterization of KRAS-Mutated Renal Cell CarcinomaAndrea Lopez Sanmiguel, Yash S Khandwala, Kuo Fengshen, et al.
Urologic Oncology|September 12, 2025
Long-term oncologic outcomes of metastatic clear-cell renal cell carcinoma after local therapy aloneDaniel Barbakoff, Mark T Dawidek, Andrea Knezevic, et al.
Medrxiv : the Preprint Server for Health Sciences|May 2, 2025
Pathologic Response to Immunotherapy is Associated with Survival in Patients Undergoing Delayed Nephrectomy for Metastatic Renal Cell CarcinomaYash S Khandwala, Stephen W Reese, Burcin A Ucpinar, et al.
European Urology Oncology|November 27, 2025
Pathologic Response to Immunotherapy Is Associated with Survival in Patients Undergoing Delayed Nephrectomy for Metastatic Renal Cell CarcinomaYash S Khandwala, Stephen W Reese, Burcin A Ucpinar, et al.
European Urology|September 9, 2025
Defining the Histopathological, Clinical, and Genetic Characteristics of Familial BAP1-associated Renal Cell CarcinomaLina Posada Calderon, Mark T Dawidek, Cerise Tang, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
The Clinical Teacher|February 25, 2026
The Trainee Perspective on Stressors During the Subinternship ProcessAndrew B Yang, Vidushi Tripathi, Daniel Barbakoff, et al.
Journal of Applied Gerontology : the Official Journal of the Southern Gerontological Society|February 25, 2026
Supportive Environmental Features at Home as Proactive/Reactive Associates of Disability and Mortality Status in Older AdultsDaniel Barbakoff, Kristen Glennie, Mengzhao Yan, et al.
Prostate Cancer and Prostatic Diseases|April 26, 2026
Predictors of fluoroquinolone-resistant bacterial colonization prior to prostate biopsy: a secondary analysis of two randomized trialsDaniel Barbakoff, Gal Wald, Mary Oakley Strasser, et al.
BJUI Compass|January 15, 2026
Long-term outcomes after cytoreductive partial nephrectomy for metastatic renal cell carcinomaAndrea Lopez Sanmiguel, Yash S Khandwala, Emily A Vertosick, et al.
Urologic Oncology|September 6, 2025
Radiomic biomarkers associated with immune checkpoint blockade response for advanced renal cell carcinomaStephen W Reese, Daniel Barbakoff, Burcin Agridag Ucpinar, et al.
Cancers|December 11, 2025
Clinical and Molecular Characterization of KRAS-Mutated Renal Cell CarcinomaAndrea Lopez Sanmiguel, Yash S Khandwala, Kuo Fengshen, et al.
Urologic Oncology|September 12, 2025
Long-term oncologic outcomes of metastatic clear-cell renal cell carcinoma after local therapy aloneDaniel Barbakoff, Mark T Dawidek, Andrea Knezevic, et al.
Medrxiv : the Preprint Server for Health Sciences|May 2, 2025
Pathologic Response to Immunotherapy is Associated with Survival in Patients Undergoing Delayed Nephrectomy for Metastatic Renal Cell CarcinomaYash S Khandwala, Stephen W Reese, Burcin A Ucpinar, et al.
European Urology Oncology|November 27, 2025
Pathologic Response to Immunotherapy Is Associated with Survival in Patients Undergoing Delayed Nephrectomy for Metastatic Renal Cell CarcinomaYash S Khandwala, Stephen W Reese, Burcin A Ucpinar, et al.
European Urology|September 9, 2025
Defining the Histopathological, Clinical, and Genetic Characteristics of Familial BAP1-associated Renal Cell CarcinomaLina Posada Calderon, Mark T Dawidek, Cerise Tang, et al.
Pageof 1